Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21311578 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed VivaGel™ in Healthy Young Women
Condition: Herpes Simplex II
Interventions: Drug: 3% w/w SPL7013 Gel;   Drug: Placebo

Indicates status has not been verified in more than two years